Curi RMB Capital LLC Has $35.63 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Curi RMB Capital LLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 387,537 shares of the medical device company's stock after selling 13,999 shares during the quarter. Cooper Companies accounts for approximately 0.8% of Curi RMB Capital LLC's holdings, making the stock its 28th biggest holding. Curi RMB Capital LLC owned approximately 0.19% of Cooper Companies worth $35,626,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. JPMorgan Chase & Co. grew its stake in shares of Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock valued at $460,066,000 after purchasing an additional 74,501 shares during the last quarter. Geode Capital Management LLC boosted its position in Cooper Companies by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after buying an additional 109,907 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after acquiring an additional 574,899 shares during the period. Norges Bank acquired a new stake in Cooper Companies in the fourth quarter worth about $217,906,000. Finally, FMR LLC raised its holdings in Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on COO. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Robert W. Baird cut their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Stock Performance

COO stock traded up $1.43 during midday trading on Thursday, reaching $82.27. 320,296 shares of the company were exchanged, compared to its average volume of 1,900,249. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The firm has a market capitalization of $16.45 billion, a price-to-earnings ratio of 42.19, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The business has a 50-day moving average price of $82.37 and a two-hundred day moving average price of $93.11. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.